Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Clinical trial NCT02276482 · COMPLETED
Trial details
- NCT number
- NCT02276482
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-25
- Primary completion
- 2018-09-17
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.